Flipping Book

Results of a phase 1 study of

177

Lu-DOTA-HH1 anti body

radionuclide (Betalutin) conjugate for patients with relapsed

CD37

non-Hodgkin lymphomas

–

Lugano 2015

177Lu-DOTA-HH1 (Betalutin)

• Murine mAb HH1

• Chelate to chemical linker

DOTA

• Beta emitting lutetium-177

(t1/2= 6.7 days)